US Patent 11492407 Bispecific checkpoint inhibitor antibodies
Patent 11492407 was granted and assigned to Xencor on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Alex Nisthal0
Christine Bonzon0
Gregory Moore0
John Desjarlais0
Matthew Bernett0
Michael Hedvat0
Umesh S. Muchhal0
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 9 Nov, 2022
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+273 characters)
US Patent 11492407 Bispecific checkpoint inhibitor antibodies
Article
The present invention is directed to heterodimeric anti-LAG-3×anti-CTLA-4. Also provided are nucleic acid compositions that encode the antibodies, expression vector compositions that include the nucleic acids, and host cells that include the expression vector compositions.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114924070
Date of Patent
November 8, 2022
0Patent Application Number
164353750
Date Filed
June 7, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11492407 Bispecific checkpoint inhibitor antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.